LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its scientists will present preclinical data for three of its oncology programs at the upcoming 102nd American Association for Cancer Research (AACR) Annual Meeting to be held in Orlando, Florida at the Orange County Convention Center on April 2-6, 2011.
